ÂÜÀòÂÒÂ×

Yukie Aizawa is a seasoned professional with over 14 years of experience in business development and drug development, focusing on neurodegenerative therapeutics and rare diseases. Currently serving as the Director of Business Development and Alliances at QurAlis, Yukie oversees in- and out-licensing initiatives and strategic partnerships. Previously, Yukie held significant roles at companies such as Bristol Myers Squibb and Shire, where they managed alliances and drove drug development strategies. Yukie's career encompasses a diverse range of experiences, including equity research and business development strategy for advanced therapies.